Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

被引：0
作者：
M. N. Olesen
K. Soelberg
B. Debrabant
A. C. Nilsson
S. T. Lillevang
J. Grauslund
I. Brandslund
J. S. Madsen
F. Paul
T. J. Smith
S. Jarius
N. Asgari
机构：
[1] Slagelse Hospital,Department of Neurology
[2] Slagelse Hospital,Department of Internal Medicine
[3] University of Southern Denmark,Epidemiology, Biostatistics and Biodemography, Department of Public Health
[4] Odense University Hospital,Department of Clinical Immunology
[5] Odense University Hospital,Department of Ophthalmology
[6] University of Southern Denmark,Department of Clinical Research
[7] Lillebælt Hospital,Department of Clinical Immunology and Biochemistry
[8] University of Southern Denmark,Institute of Regional Health Research
[9] Charité - Universitätsmedizin Berlin,Clinical and Experimental Multiple Sclerosis Research Center and NeuroCure Clinical Research Center, Department of Neurology
[10] Max Delbrueck Center for Molecular Medicine and Charité – Universitätsmedizin Berlin,Experimental and Clinical Research Center
[11] University of Michigan Medical School,Departments of Ophthalmology and Visual Sciences and Internal Medicine
[12] University Hospital Heidelberg,Molecular Neuroimmunology Group, Department of Neurology
[13] University of Southern Denmark,Institutes of Regional Health Research and Molecular Medicine
[14] Odense University Hospital,Odense Patient data Explorative Network (OPEN)
来源：
Journal of Neuroinflammation | / 16卷
关键词：
Immunology; Optic neuritis; Multiple sclerosis; Cerebrospinal fluid; Biomarkers; Inflammation; Neurodegeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 145 条
  • [1] Petzold A(2014)The investigation of acute optic neuritis: a review and proposed protocol Nat Rev Neurol 10 447-458
  • [2] Wattjes MP(2014)Optic neuritis The Lancet Neurology. 13 83-99
  • [3] Costello F(2016)MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients J Neuroinflammation 13 282-481
  • [4] Flores-Rivera J(2014)Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders Neurology. 82 474-283
  • [5] Fraser CL(2014)Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study JAMA Neurol 71 276-173
  • [6] Fujihara K(2016)MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin J Neuroinflammation 13 279-302
  • [7] Toosy AT(2018)Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria The Lancet Neurology 17 162-6099
  • [8] Mason DF(2011)Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Ann Neurol 69 292-211
  • [9] Miller DH(2007)Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis J Immunol 178 6092-1093
  • [10] Pache F(2006)Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment Brain J Neurol 129 200-36
12345678910